Key achievements

Our mission is to help people do more, feel better, live longer. Discover some of our milestones on the way to that mission.

  • 100%

    of our markets now operating the new commercial model.

  • £3.6bn

    We invested £3.6 billion in 2016 in our search to develop new medicines, vaccines and consumer products.

  • 20–30

    We expect important data on between 20 and 30 assets in areas including HIV, respiratory, immuno-inflamation and oncology.

  • 87

    We have a network of 87 manufacturing sites, and large R&D centres in the UK, US and Belgium.

  • 1st

    in the Access to Medicines Index since launch in 2008

  • 11,500

    More than 11.500 people work in R&D in our search for new medicines, vaccines and consumer healthcare products.

  • 833m

    In 2016, we distributed more than 833 million doses of vaccines around the world.

  • 99,300

    We employ more than 99,300 people in over 150 countries, with more than a third of these in emerging markets.